REGULATION OF LYMPHOCYTE PROLIFERATION AND REPLICATIVE CAPACITY
REGULATION OF LYMPHOCYTE PROLIFERATION AND REPLICATIVE CAPACITY
批准号:
6100990
负责人:
R J HODES
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
DNA directed DNA polymerase cell cycle cell differentiation enzyme activity enzyme induction /repression helper T lymphocyte human tissue immunogenetics immunologic memory immunoregulation leukopoiesis lymphocyte proliferation restriction fragment length polymorphism restriction mapping telomerase telomere tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The replicative history and replicative potential of human naive and
memory T cells, critical parameters of lymphocyte biology, were
analyzed. Telomeres are unique terminal chromosomal structures which
shorten with cell division in vitro and with increased age in vivo for
human somatic cells. We assessed telomere length as a measure of the in
vivo replicative history of naive and memory human T cells, and found
that telomeric terminal restriction fragments were 1.4 q 0.1 kb longer
in CD4+ naive T cells than in memory cells from the same donors, a
relationship that was constant over a wide range of donor age. This
suggests that the differentiation of memory cells from naive precursors
occurs with substantial clonal expansion that is similar over a wide age
range. The in vitro replicative capacity of naive cells was 128-fold
greater than that of memory cells from the same donors. Human CD4+ naive
and memory cells thus differ in in vivo replicative history as reflected
in telomeric length as well as in their residual replicative capacity.
These relationships may be significant for pathologies such as HIV
infection, in which CD4+ T cell generation may be compromised, and for
therapeutic interventions mediated by cells whose in vivo expansion is
essential for therapeutic effect.
Analysis of telomere length regulation in human B cells demonstrated
that germinal center(GC)B cells have significantly longer telomeres than
the naive B cells that are their precursors or the memory B cells that
are their progeny. These results suggest the novel possibility that
normal somatic cells of the B lymphocyte lineage express a mechanism
capable of extending telomere length. Such a mechanism might function
to extend the capacity for clonal expansion of memory and effector B
cells.
Telomerase, a ribonucleoprotein enzyme that is capable of synthesizing
telomeric repeats, is expressed in germline and malignant cells and is
absent in most normal human somatic cells. The selective expression of
telomerase has thus been proposed to be a basis for the immortality of
the germline and of malignant cells. When telomerase activity was
analyzed in normal human T lymphocytes, it was found that telomerase is
expressed at a high level in thymocytes, at an intermediate level in
tonsil T cells, and at a low to undetectable level in peripheral blood
T cells. Moreover, telomerase activity was highly inducible in
peripheral T lymphocytes by activation through CD3 and CD28 (anti-
CD3/CD28). Telomerase may thus play a permissive role in T cell
development and in determining the capacity of lymphoid cells for clonal
expansion.
In differentiating human tonsil B cells, it was demonstrated that
telomerase is expressed specifically at a high level in GC B cells.
Expression of telomerase in these cells may provide a mechanism for the
apparent telomere lengthening that occurs in differentiation from
precursor to GC B cells.
A model system has been established for analysis of the genetic
regulation of telomere length in mice. Inter-fertile species of mice
were identified which differ significantly in telomere length. Crosses
between these species have in initial experiments demonstrated that 1)
a mechanism exists for substantial telomere lengthening in somatic cells
in vivo, and 2) that species-specific telomere length is regulated by
segregating genes that are polymorphic between these species.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF LYMPHOCYTE PROLIFERATION AND CELL CYCLE PROGRESSION
-
批准号:2463800
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
T CELL REGULATION AND B CELL ACTIVATION
-
批准号:2463766
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
RECEPTOR MEDIATED T AND B CELL ACTIVATION
-
批准号:2463770
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
IMMUNE RESPONSE GENE REGULATION OF IMMUNE RESPONSE IN VITRO
-
批准号:4691763
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
RECEPTOR MEDIATED T CELL ACTIVATION
-
批准号:3963093
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
RECEPTOR MEDIATED T CELL ACTIVATION
-
批准号:3939369
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
RECEPTOR MEDIATED T AND B CELL ACTIVATION
-
批准号:3752100
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
IMMUNE RESPONSE GENE REGULATION OF THE IMMUNE RESPONSE IN VITRO
-
批准号:3813459
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
ANALYSIS OF THE T CELL REPERTOIRE
-
批准号:3813463
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
ANALYSIS OF THE T CELL REPERTOIRE
-
批准号:3796544
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
RECEPTOR MEDIATED T AND B CELL ACTIVATION
-
批准号:3774397
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
ANALYSIS OF THE T CELL REPERTOIRE
-
批准号:3774391
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
T CELL REGULATION OF B CELL ACTIVATION
-
批准号:6161057
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
EXPRESSION OF IA ANTIGENS ON FUNCTIONAL CELL SUBPOPULATIONS
-
批准号:3939234
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
T CELL REGULATION OF B CELL ACTIVATION
-
批准号:3813464
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
EXPRESSION OF IA ANTIGENS ON FUNCTIONAL CELL SUBPOPULATIONS
-
批准号:4691761
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
T CELL REGULATION OF B CELL ACTIVATION
-
批准号:4691772
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
RECEPTOR MEDIATED T CELL ACTIVATION
-
批准号:3796551
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
IMMUNOTHERAPY OF HUMAN CANCER
-
批准号:3813454
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
T CELL REGULATION OF B CELL ACTIVATION
-
批准号:3939242
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R J HODES
-
依托单位:
海外基金